Sign in

CIK 0001826457 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Monte Rosa Therapeutics, Inc.

Sign in to watch
Ticker
GLUE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-949-2643
Business address
321 HARRISON AVENUE, SUITE 900, BOSTON, MA, 02118
Former names
Monte Rosa Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$137
in 1 filing

Net −$137. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Bowen Matthew −$137 Principal Accounting Officer sold <1% of stake

Reading 35 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-01-03 Nickson Philip General Counsel Grant or award · Stock Option (Right to Buy) +123,650 123,650
2023-01-03 Warmuth Markus President & CEO Grant or award · Stock Option (Right to Buy) +472,000 472,000
2023-01-03 Castle John C. Chief Data Scientist Grant or award · Stock Option (Right to Buy) +78,500 78,500
2023-01-03 Townson Sharon Chief Technology Officer Grant or award · Stock Option (Right to Buy) +78,550 78,550
2023-01-03 Tamboli Ajim Chief Financial Officer Grant or award · Stock Option (Right to Buy) +129,850 129,850
2023-01-03 Jones Jullian G Chief Business Officer Grant or award · Stock Option (Right to Buy) +77,450 77,450
2023-01-03 Janku Filip Chief Medical Officer Grant or award · Stock Option (Right to Buy) +135,000 135,000
2022-12-15 Janku Filip Chief Medical Officer Grant or award · Stock Option (Right to Buy) +36,000 36,000
2022-10-31 Janku Filip Chief Medical Officer Grant or award · Stock Option (Right to Buy) +36,000 36,000
2022-06-15 Behbahani Ali Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2022-06-15 Siu Christine Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2022-06-15 SCHIFF ANDREW N Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2022-06-15 Mayweg Alexander Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2022-06-15 Blackwell Kimberly Director Grant or award · Stock Option (Right to Buy) +15,000 15,000

Page 9 of 9 · 174 trades